# Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)

> **NCT00724932** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 140 (actual)

## Conditions studied

- Anesthesia, General

## Interventions

- **DRUG:** Rocuronium
- **DRUG:** Sugammadex
- **DRUG:** Neostigmine
- **DRUG:** Atropine

## Key facts

- **NCT ID:** NCT00724932
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-16
- **Primary completion:** 2009-04-01
- **Final completion:** 2009-05-03
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2017-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00724932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00724932, "Comparison of Sugammadex With Neostigmine During Laparoscopic Cholecystectomy or Appendectomy (P05699)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00724932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*